InvestorsHub Logo
Followers 32
Posts 10384
Boards Moderated 0
Alias Born 04/20/2016

Re: stockpicker1 post# 3773

Tuesday, 10/09/2018 10:04:39 AM

Tuesday, October 09, 2018 10:04:39 AM

Post# of 5006
I figure future float all in 60 million. NIMH only funded pain and current phase 2A pain. The phase 2 adjunctive is underway and is funded 100 percent by company.

Extremely qualified Harvard team running trial and patented trial procedure which has proven.

APTX recently went public at 16 and nearly hit 30. That was NAurex pain drug. It has about a 900 million market cap now

3 potential blockbusters here,

Pain
Depression
Anxiety

All oral. Sign drug intravenous and J&J drug is nasal but needs to be given by doctor.

How much of a factor will an oral drug have over drugs that require doctors visits...

Plus a stem cell company.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent VTGN News